 I make it a fairly regular habit of having a look at companies that care about their dividend. The dividend aristocrat list has always been a good starting place for me as these stocks have a proven track record of tailoring themselves to the dividend investor. Abbott Labs appears in the 2009 version of this list.
To put a full review of Abbott would make for a long post, and not a particularly interesting one, so I’ll instead restrict myself to looking at a few key elements from the company’s fundementals. Perhaps this will help to add to the research you have already performed on Abbott or suggest some alternative ways that you can look at other companies.
Read More...
|
Every day I pull a list of the insider traders then I shorten the list to be only buys done by roles that have a proven track record (see my previous post for a little on this). Finally I run an evaluation of the companies based on some of the ratios that Graham used to find companies that are cheap (See my earlier series on this).
This is just the start for me though after a company reaches this level it is worthy enough for me to look at it further not necessarily.
Read More...
|
| |
| |
|
